(Q39392535)

11 September 2017

title

Prostate cancer cell surface-associated keratin 8 and its implications for enhanced plasmin activity (English)

1 reference

11 September 2017

1 reference

Melissa Hirsch Kuchma

1

1 reference

11 September 2017

Joo Hee Kim

2

1 reference

11 September 2017

Mark T Muller

3

1 reference

11 September 2017

Philip A Arlen

4

1 reference

11 September 2017

publication date

1 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

31

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

195-205

1 reference

The urokinase-type plasminogen activator system in cancer metastasis: a review

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Expression of complete keratin filaments in mouse L cells augments cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Monoclonal antibody to cytokeratin VKIALEVEIATY sequence motif reduces plasminogen activation in breast tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cytokeratin 8 associates with the external leaflet of plasma membranes in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Characterization of the binding sites for plasminogen and tissue-type plasminogen activator in cytokeratin 8 and cytokeratin 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cell cycle-dependent Ca2+ oscillations in mouse embryos are regulated by nuclear targeting of PLCzeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Targeting uPA/uPAR in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cell cycle-dependent expression of thyroid hormone receptor-beta is a mechanism for variable hormone sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

The human keratins: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Implications of cytokeratin 8/18 filament formation in stratified epithelial cells: induction of transformed phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Receptors for plasminogen and t-PA: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

The urokinase-type plasminogen activator system in prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Cancer to bone: a fatal attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Molecular mechanism of physiological fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-011-9388-Z

Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo

21 January 2018

1 reference

12 December 2020

Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas

1 reference

12 December 2020

Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway

1 reference

12 December 2020

Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies.

1 reference

12 December 2020

Integrin expression and usage by prostate cancer cell lines on laminin substrata.

1 reference

12 December 2020

Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas

1 reference

12 December 2020

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

1 reference

12 December 2020

Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients

1 reference

12 December 2020

A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines

1 reference

12 December 2020

Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.

1 reference

12 December 2020

Analysis of bone metastasis of prostatic adenocarcinoma in 137 autopsy cases

1 reference

12 December 2020

Cell cycle regulation of glucocorticoid receptor function

1 reference

12 December 2020

Analysis of DNA content and green fluorescent protein expression

1 reference

12 December 2020

On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin

1 reference

12 December 2020

Presence of proteolytically processed keratins in the culture medium of MCF-7 cells.

1 reference

12 December 2020

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone

1 reference

12 December 2020

10.1007/S10930-011-9388-Z

Identifiers

DOI

1 reference

11 September 2017

1 reference